Case Report: Hypertriglyceridemia-Induced Pancreatitis after Lenvatinib and Pembrolizumab Use

Abstract Introduction: Lenvatinib and Pembrolizumab together are used as a chemotherapy regimen for patients with metastatic endometrial carcinoma. Lenvatinib is a vascular endothelial growth factor (VEGF) receptor inhibitor, fibroblast growth factor inhibitor and an inhibitor that acts on platelet...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Case reports in oncology 2024-01, Vol.17 (1), p.311-316
Hauptverfasser:	Sultan, Kinza, Khan, Ziad, Saadat, Siamak
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Acidosis Cancer therapies Case Report Case reports Chemotherapy Conflicts of interest Drug dosages Edema Emergency medical care Endometrial cancer endometrial carcinoma Fatty acids Growth factors Hematology Hypertension hypertriglyceridemia-induced pancreatitis Hysterectomy Immunotherapy Inflammation Insulin Ischemia Lipids Metastasis Monoclonal antibodies Oncology Pathophysiology Patients Review boards Targeted cancer therapy Triglycerides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!